1 / 16

Abu Raihan, MD, MPH Director of Program, Asia Email: abu.raihan@orbis

Symposium 6: Challenges in Monitoring Clinical Program Outcomes Developing an Institution-Wide M &E paradigm: The ORBIS experience. Abu Raihan, MD, MPH Director of Program, Asia Email: abu.raihan@orbis.org IAPB 9th GA, Hyderabad, 17-20 September 2012. Outline.

marge
Télécharger la présentation

Abu Raihan, MD, MPH Director of Program, Asia Email: abu.raihan@orbis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Symposium 6: Challenges in Monitoring Clinical Program Outcomes Developing an Institution-Wide M &E paradigm: The ORBIS experience Abu Raihan, MD, MPH Director of Program, Asia Email: abu.raihan@orbis.org IAPB 9th GA, Hyderabad, 17-20 September 2012

  2. Outline • Definition and purpose of M&E • ORBIS Paradigm: Importance of clinical outcomes • Principles of choosing and using key outcomes • Multi-tier challenges & barriers to data collection • Conclusions

  3. Monitoring • Systematic and routine collection of information from the on-going programs for three main purposes: • To have internal and external accountability of the resources used and the results obtained • To learn from experience to improve practice and take informed decisions • To empower partners to deliver quality care

  4. Evaluation • Assessing systematically and objectively the value of program. • Evaluations help to draw conclusions about five main aspects of the interventions: • Relevance • Effectiveness • Efficiency • Impact • Sustainability

  5. Key Elements in Designing the M&E Framework • Define relevant indicators and their measures; • Identify and set benchmarks/standards; • Determine data collection strategy; • Analyze data and prepare reports for dissemination and decision making.

  6. Purpose of Institution-wide Approach of M&E • It is one of the important component of program planning, development and implementation • Standardization of data collection and information flow • Provides checks and balances over program planning and implementation • Strong M&E leads to transparency and good governance for an organization

  7. ORBIS Paradigm: Importance of Measuring Clinical Outcomes • To measure excellence in training and practice for quality patient care • To provide evidence for advocacy to persuade policy makers, partners to promote good quality eye health • Demonstrate impact of good vision on individuals, families and on communities • Sustainability ensured when good outcomes attract patients

  8. Principles for Choosing Key Outcomes • Outcomes must be appropriateandpractical to collect by partners • Outcomes reflect quality • Outcome data supports Continuous Quality Improvement process

  9. Complexity of Clinical Outcomes • There is no one standard for all diseases • For certain complex procedures, outcomes are the result of expert consultations • Pediatric cataract, glaucoma • ROP • Retina • Current standards are based on international best practices - PPP • This is a good place to start, however, these outcomes may need to be adapted as we put them into practice.

  10. Internal Challenges • Data collection: who what when how frequent • Cost to implement strategy: information system and other resources • Which software to manage data on the outcomes? • Willingness and ability of staff / partners to collect • Analysis, use, and dissemination of results- requires additional skills

  11. External Challenges • Cultural issues, not valuing the purpose • Suspicion and fear • System and resources lacking • Privacy / legal issues in some countries to patient data with foreign NGOs • Partners feel alienated from M&E process. • Often they have no inputs in the process- “one-size-fits-all” requirements • One-way, upward accountability, very little feedback loop.

  12. Barriers to Outcome Data • No systems to collect/collate data • No culture to record • Suspicion/fear of recording Sub-Saharan Africa Barriers to data availability India • Limited systems to collate • Suspicion/Fear of sharing+/- USA Lack of information • Good patient note • Published and publicly available outcome data

  13. Practical Approach to Clinical Outcomes • Invest resources for • Staff, training, and retention • System for data collection and management • Develop capacity to analyze data and give partners feedback on the results: close the loop! • Build or strengthen capacity of partners toward clinical excellence in practice • Bringing Ophthalmologists on board is the key !

  14. Areas for Debate • Should current standards be universal across all countries? • What are context specific appropriate standards? • Ho do we change the culture?

  15. Conclusions • Challenges exist, though most can be addressed through appropriate investment in resources • Attitudes and perceptions are crucial but are often difficult to change • The shift to include measurement of clinical outcomes is critical to good quality eye care programs for elimination of blindness.

  16. Thank you

More Related